Cantitate/Preț
Produs

Impact of Genetic Targets on Cancer Therapy: Advances in Experimental Medicine and Biology, cartea 779

Editat de Wafik S. El-Deiry
en Limba Engleză Hardback – 4 ian 2013
​​​The volume provides a forum for original peer-reviewed short communications, full-length research and review articles on new research findings and developments on the topic of genetic targets on cancer therapies. As the field is highly important it requires co-operation between research communities from all over the world to share their knowledge and experience in order to move the field forward. Each chapter includes a discussion of the impact of the tumor microenvironment and cancer stem cells and cover current knowledge in this area as it pertains to the disease, including emerging therapy targeting the microenvironment and/or cancer stem cells.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 139453 lei  6-8 săpt.
  Springer – 8 feb 2015 139453 lei  6-8 săpt.
Hardback (1) 139900 lei  6-8 săpt.
  Springer – 4 ian 2013 139900 lei  6-8 săpt.

Din seria Advances in Experimental Medicine and Biology

Preț: 139900 lei

Preț vechi: 147263 lei
-5% Nou

Puncte Express: 2099

Preț estimativ în valută:
26783 27839$ 22206£

Carte tipărită la comandă

Livrare economică 07-21 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461461753
ISBN-10: 1461461758
Pagini: 456
Ilustrații: VIII, 448 p.
Dimensiuni: 155 x 235 x 28 mm
Greutate: 0.75 kg
Ediția:2013
Editura: Springer
Colecția Springer
Seria Advances in Experimental Medicine and Biology

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

​​​Novel antineoplastics targeting genetic changes in colorectal cancer.- Update on Clinical Trials: Genetic Targets in Breast Cancer.- Impact of Genetic Targets on Cancer Therapy in Esophagogastric Cancer.- Impact of Genetic Targets on Cancer Therapy: Liver Cancer.- Targeting the molecular phenotype of pancreatic cancer toward the goal of patient-tailored therapy.- Impact of genetic markers on treatment of Non-small cell lung cancer.- Impact of Genetic Targets on Therapy in Head and Neck Squamous Cell Carcinoma.- Tyrosine Kinase Targeted Treatment of Chronic Myelogenous Leukemia and Other Myeloproliferative Neoplasms.- Targeted Therapy of Multiple Myeloma.- Current and Future Trials of Targeted Therapies in Cutaneous Melanoma.- Current Approaches to Epigenetic therapy for the treatment of Mantle Cell Lymphoma.- Impact of Genetic Targets on Primary Brain Tumor Therapy: What’s Ready for Prime Time?.- Rational therapy for renal cell carcinoma based on its genetic targets.- Molecular and Genetic Markers of Follicular-Cell Thyroid Cancer: Etiology and Diagnostic and Therapeutic Opportunities.- Genetic Targets in Pediatric Acute Lymphoblastic Leukemia.- Emerging molecular therapies for the treatment of Acute Lymphoblastic Leukemia.- Impact of Genetic Targets on Prostate Cancer Therapy.- Small-Cell Lung Cancer: An Update on Targeted Therapies.- Impact of Genetic Targets on Cancer Therapy in Acute Myelogenous Leukemia.- Index.

Notă biografică

Wafik S. El-Deiry, M.D., Ph.D, is Professor of Medicine, Chief, Hematology/Oncology, Rose Dunlap Division Chair in Hematology/Oncology, and Associate Director for Translational Researchat Penn State Hershey Cancer Institute. Dr. El-Deiry is a well-respected and notable figure among cancer researchers, scientists, and clinicians. He has published almost 300 papers in his career and has over 29,000 totol citations, with an excellent h-index of 70.

Caracteristici

Comprehensive coverage how genetic targets impacts cancer therapy over a full spectrum of different cancers Contributors are top experts on their topics An emerging trend in cancer is an interest in the impact of genetic targets to current cancer therapies Includes supplementary material: sn.pub/extras